Your browser doesn't support javascript.
loading
The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trial.
Xuan, Li; Dai, Min; Jiang, Erlie; Wang, Yu; Huang, Fen; Fan, Zhiping; Xu, Na; Nie, Danian; Liang, Xinquan; Chen, Hong; Ye, Jieyu; Shi, Pengcheng; Liu, Hui; Jin, Hua; Lin, Ren; Yan, Chenhua; Zhang, Yu; Sun, Jing; Han, Mingzhe; Liu, Qifa.
Afiliação
  • Xuan L; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Dai M; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Jiang E; Hematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China.
  • Wang Y; Department of Hematology, Peking University People's Hospital, Beijing, China.
  • Huang F; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Fan Z; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xu N; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Nie D; Department of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Liang X; Department of Hematology, the First People's Hospital of Chenzhou, Chenzhou, China.
  • Chen H; Department of Hematology, Liuzhou Worker's Hospital, Liuzhou, China.
  • Ye J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Shi P; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Jin H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Lin R; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yan C; Department of Hematology, Peking University People's Hospital, Beijing, China.
  • Zhang Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Sun J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Han M; Hematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China.
  • Liu Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Electronic address: liuqifa628@163.com.
Lancet Haematol ; 10(3): e178-e190, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36702138
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Anemia Refratária com Excesso de Blastos / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Clinical_trials / Etiology_studies Limite: Female / Humans / Male Idioma: En Revista: Lancet Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Anemia Refratária com Excesso de Blastos / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Clinical_trials / Etiology_studies Limite: Female / Humans / Male Idioma: En Revista: Lancet Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido